BIOLASE, Inc. (BIOLQ)

BIOLASE Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3.44	6.57	4.18	29.97	17.56	5.79
Cash & Short-Term Investments	3.44	6.57	4.18	29.97	17.56	5.79
Cash Growth	-55.90%	57.04%	-86.05%	70.64%	203.40%	-28.03%
Accounts Receivable	3.53	5.48	5.84	4.24	3.06	8.76
Other Receivables	-	-	-	-	1.5	-
Receivables	3.53	5.48	5.84	4.24	4.56	8.76
Inventory	9.87	11.67	17.11	13.51	11.16	11
Prepaid Expenses	2.58	0.59	0.66	0.68	0.95	0.8
Restricted Cash	-	-	-	0.2	0.31	0.31
Other Current Assets	-	0.56	1.17	0.75	0.57	0.36
Total Current Assets	19.43	24.86	28.96	49.35	35.11	27.02
Property, Plant & Equipment	4.63	7.04	6.05	2.78	2.76	1.47
Goodwill	2.93	2.93	2.93	2.93	2.93	2.93
Other Long-Term Assets	0.26	0.27	0.26	0.22	0.23	0.43
Total Assets	27.24	35.1	38.19	55.28	41.03	31.85

Liabilities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Accounts Payable	3	6.07	5.79	3.31	2.65	5.33
Accrued Expenses	4.53	4.86	6.85	5.94	5.45	3.31
Current Portion of Long-Term Debt	16.04	2.27	0.7	-	-	13.47
Current Portion of Leases	0.86	0.89	0.64	0.41	0.31	0.32
Current Income Taxes Payable	0.39	0.45	0.43	0.56	0.17	0.24
Current Unearned Revenue	2.23	2.45	2.11	2.26	1.91	2.24
Other Current Liabilities	2.24	2.68	1.29	1.37	0.75	0.87
Total Current Liabilities	29.28	19.66	17.81	13.84	11.22	25.78
Long-Term Debt	-	11.78	13.09	13.6	16.19	-
Long-Term Leases	0.21	0.77	1.26	1.45	1.77	0
Long-Term Unearned Revenue	0.22	0.26	0.42	0.33	0.37	0.36
Other Long-Term Liabilities	0.83	0.67	0.72	0.85	1.44	1.36
Total Liabilities	30.54	33.15	33.3	30.08	31	27.51

Shareholders' Equity

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Common Stock	0.04	0	-	0.01	0.1	0.03
Additional Paid-In Capital	322.78	317.1	301.79	293.33	261.57	235.59
Retained Earnings	-327.51	-316.8	-296.17	-267.53	-251.38	-234.55
Comprehensive Income & Other	-0.53	-0.55	-0.73	-0.62	-0.39	-0.7
Total Common Equity	-5.23	-0.25	4.89	25.17	9.91	0.38
Shareholders' Equity	-3.3	1.96	4.89	25.21	10.03	4.34
Total Liabilities & Equity	27.24	35.1	38.19	55.28	41.03	31.85

Additional Metrics

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total Debt	17.11	15.71	15.69	15.46	18.27	13.79
Net Cash (Debt)	-13.67	-9.14	-11.51	14.52	-0.7	-8
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.60	-7.15	-166.77	246.02	-28.67	-
Filing Date Shares Outstanding	36.6	32.52	0.26	0.06	0.06	0.01
Total Common Shares Outstanding	36.6	3.42	0.08	0.06	0.04	0.01
Working Capital	-9.85	5.2	11.15	35.51	23.89	1.24
Book Value Per Share	-0.14	-0.07	63.32	409.53	253.68	29.98
Tangible Book Value	-8.15	-3.17	1.96	22.25	6.98	-2.55
Tangible Book Value Per Share	-0.22	-0.93	25.42	361.93	178.78	-202.69
Land	0.16	0.16	0.16	0.16	0.18	0.16
Buildings	0.21	0.21	0.2	0.21	0.23	0.21
Machinery	13.33	15.15	9.04	8.62	7.94	8.11
Construction In Progress	-	0.09	2.96	0.03	0.05	0.03
Leasehold Improvements	1.25	1.25	0.46	0.09	0.05	2

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error